How to manage DOAC-related bleeding

10' education - Mar. 8, 2018 - Prof. Menno Huisman (The Netherlands) and dr. Alexander Cohen (UK)

Video navigation menu

Is management of DOAC-related bleeding different from a bleeding on warfarin? 0:25
Is it necessary to classify patients or the bleeding, to know how to act? 1:06
Having a hospital-specific protocol on management of DOAC- or VKA-related bleeding is important 2:12
Renal function shoulds be assessed in the context of DOAC treatment 3:54
Outcomes of patients who bleed on DOACs, in the context of reversal agents 4:17

Faculty

Prof. Menno Huisman - LUMC, Leiden, The Netherlands

Alexander Cohen, MD King's College, London, United Kingdom

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme. Funding was provided by an unrestricted educational grant from Pfizer/BMS.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.